Study of Ataluren in Nonsense Mutation Cystic Fibrosis (ACT CF)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Joseph McIntosh, MD
PTC Therapeutics
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
88 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital Universitario Austral
Buenos Aires, Argentina
- Hospital de Niños Dr. Ricardo Gutiérrez
Buenos Aires, Argentina
- Hospital de Niños Superiora Sor Maria Ludovica
La Plata, Argentina
- Royal Adelaide Hospital
Adelaide, Australia
- Prince Charles Hospital
Chermside, Australia
- Princess Margaret Hospital
Perth, Australia
- Hôpital Universitaire Des Enfants Reine Fabiola
Brussels, Belgium
- University Hospital Brussels
Brussels, Belgium
- University Hospital Leuven
Leuven, Belgium
- Hospital Sao Lucas Da Pontificia Universidade Catolica Do Rio Grande Do Sul
Porto Alegre, Brazil
- Instituto Da Criança - Hospital Das Clínicas
São Paulo, Brazil
- University Mulitiprofile Hospital for Active Treatment Sveti Georgi Ead
Plovdiv, Bulgaria
- University Multiprofile Hospital for Active Treatment Aleksandrovska Ead
Sofia, Bulgaria
- Clinical Research Institute of Montreal
Montreal, Canada
- Chu de Quebec - Hopital Chul
Québec, Canada
- University of Toronto Hospital for Sick Children
Toronto, Canada
- British Columbia Children'S Hospital
Vancouver, Canada
- Hôpital Femme-Mère-Enfant
Bron, France
- Hôpital Arnaud de Villeneuve
Montpellier, France
- Hôpital Necker-Enfants Malades
Paris, France
- Centre de Perharidy
Roscoff, France
- Centre Hospitalier Regional Sud Reunion
Saint-Pierre, France
- Charité Universitätsmedizin Berlin
Berlin, Germany
- St. Josef Hospital Gmbh
Bochum, Germany
- Universitätsklinikum Köln
Cologne, Germany
- Christiane Herzog Cf-Zentrum
Frankfurt am Main, Germany
- Universitätsklinikum Jena
Jena, Germany
- Dr. Von Haunersches Kinderspital
München, Germany
- Lmu Klinikum Der Universität München
München, Germany
- General Hospital of Thessaloniki Ippokration
Thessaloniki, Greece
- Meyer Children'S Hospital
Haifa, Israel
- Hadassah University Hospital
Jerusalem, Israel
- Ospedali Riuniti Di Ancona
Ancona, Italy
- Azienda Ospedaliera A Meyer
Florence, Italy
- Lombardia Cystic Fibrosis Center
Milan, Italy
- Ospedale Pediatrico Bambino Gesù Irccs
Roma, Italy
- Azienda Policlinico Umberto I
Rome, Italy
- University of Verona
Verona, Italy
- Radboud University
Nijmegen, Netherlands
- Erasmus Mc
Rotterdam, Netherlands
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2014
- Primary completion
- 30 Nov 2016
- Completion
- 30 Nov 2016
- Last update posted
- 14 May 2020
- Registered enrollment
- 279
- Registry id
- NCT02139306
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.